These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.
208 related articles for article (PubMed ID: 16832833)
1. Identifying Smith-Lemli-Opitz syndrome in conjunction with prenatal screening for Down syndrome. Craig WY; Haddow JE; Palomaki GE; Kelley RI; Kratz LE; Shackleton CH; Marcos J; Stephen Tint G; MacRae AR; Nowaczyk MJ; Kloza EM; Irons MB; Roberson M Prenat Diagn; 2006 Sep; 26(9):842-9. PubMed ID: 16832833 [TBL] [Abstract][Full Text] [Related]
2. Major fetal abnormalities associated with positive screening tests for Smith-Lemli-Opitz syndrome (SLOS). Craig WY; Haddow JE; Palomaki GE; Roberson M Prenat Diagn; 2007 May; 27(5):409-14. PubMed ID: 17286308 [TBL] [Abstract][Full Text] [Related]
3. Prenatal diagnosis of the RSH/Smith-Lemli-Opitz syndrome. Kratz LE; Kelley RI Am J Med Genet; 1999 Feb; 82(5):376-81. PubMed ID: 10069707 [TBL] [Abstract][Full Text] [Related]
4. Recent advances in maternal serum screening for Down syndrome. Messerlian GM; Canick JA Med Health R I; 2002 Dec; 85(12):362-5. PubMed ID: 12593353 [TBL] [Abstract][Full Text] [Related]
5. Maternal urine and serum steroid measurements to identify steroid sulfatase deficiency (STSD) in second trimester pregnancies. Marcos J; Craig WY; Palomaki GE; Kloza EM; Haddow JE; Roberson M; Bradley LA; Shackleton CH Prenat Diagn; 2009 Aug; 29(8):771-80. PubMed ID: 19418464 [TBL] [Abstract][Full Text] [Related]
6. Prenatal diagnosis of Smith-Lemli-Opitz syndrome (SLOS) by DHCR7 mutation analysis. Waye JS; Eng B; Nowaczyk MJ Prenat Diagn; 2007 Jul; 27(7):638-40. PubMed ID: 17441222 [TBL] [Abstract][Full Text] [Related]
7. Maternal urinary steroid profiles in prenatal diagnosis of Smith-Lemli-Opitz syndrome: first patient series comparing biochemical and molecular studies. Jezela-Stanek A; Małunowicz EM; Ciara E; Popowska E; Goryluk-Kozakiewicz B; Spodar K; Czerwiecka M; Jezuita J; Nowaczyk MJ; Krajewska-Walasek M Clin Genet; 2006 Jan; 69(1):77-85. PubMed ID: 16451140 [TBL] [Abstract][Full Text] [Related]
8. Difficult prenatal diagnosis in mild Smith-Lemli-Opitz syndrome. Nowaczyk MJ; Heshka T; Kratz LE; Kelley RE Am J Med Genet; 2000 Dec; 95(4):396-8. PubMed ID: 11186897 [TBL] [Abstract][Full Text] [Related]
9. Assigning risk for Smith-Lemli-Opitz syndrome as part of 2nd trimester screening for Down's syndrome. Palomaki GE; Bradley LA; Knight GJ; Craig WY; Haddow JE J Med Screen; 2002; 9(1):43-4. PubMed ID: 11943798 [TBL] [Abstract][Full Text] [Related]
10. Molecular prenatal diagnosis of Smith-Lemli-Opitz syndrome is reliable and efficient. Loeffler J; Utermann G; Witsch-Baumgartner M Prenat Diagn; 2002 Sep; 22(9):827-30. PubMed ID: 12224080 [TBL] [Abstract][Full Text] [Related]
11. Fetal Smith-Lemli-Opitz syndrome can be detected accurately and reliably by measuring amniotic fluid dehydrocholesterols. Tint GS; Abuelo D; Till M; Cordier MP; Batta AK; Shefer S; Honda A; Honda M; Xu G; Irons M; Elias ER; Salen G Prenat Diagn; 1998 Jul; 18(7):651-8. PubMed ID: 9706645 [TBL] [Abstract][Full Text] [Related]
12. [Screening for Down syndrome using first-trimester combined screening followed by second trimester ultrasound examination in an unselected population]. Rozenberg P; Bussières L; Chevret S; Bernard JP; Malagrida L; Cuckle H; Chabry C; Durand-Zaleski I; Bidat L; Lacroix I; Moulis M; Roger M; Jacquemot MC; Bault JP; Boukobza P; Boccara P; Vialat F; Giudicelli Y; Ville Y Gynecol Obstet Fertil; 2007 Apr; 35(4):303-11. PubMed ID: 17350315 [TBL] [Abstract][Full Text] [Related]
13. High-throughput urine screening for Smith-Lemli-Opitz syndrome and cerebrotendinous xanthomatosis using negative electrospray tandem mass spectrometry. Pitt JJ Clin Chim Acta; 2007 May; 380(1-2):81-8. PubMed ID: 17341417 [TBL] [Abstract][Full Text] [Related]
14. Cost-effectiveness model for first-trimester versus second-trimester ultrasound screening for Down syndrome. Kott B; Dubinsky TJ J Am Coll Radiol; 2004 Jun; 1(6):415-21. PubMed ID: 17411619 [TBL] [Abstract][Full Text] [Related]
16. Smith-Lemli-Opitz syndrome: prenatal diagnosis by quantification of cholesterol precursors in amniotic fluid. Rossiter JP; Hofman KJ; Kelley RI Am J Med Genet; 1995 Apr; 56(3):272-5. PubMed ID: 7778588 [TBL] [Abstract][Full Text] [Related]
17. Smith-Lemli-Opitz syndrome and other sterol disorders among Finns with developmental disabilities. Nissinen MJ; Gylling H; Kaski M; Tammisto P; Mieskonen S; Ignatius J; Miettinen TA J Lab Clin Med; 2000 Dec; 136(6):457-67. PubMed ID: 11128747 [TBL] [Abstract][Full Text] [Related]
18. First- and second-trimester screening: detection of aneuploidies other than Down syndrome. Breathnach FM; Malone FD; Lambert-Messerlian G; Cuckle HS; Porter TF; Nyberg DA; Comstock CH; Saade GR; Berkowitz RL; Klugman S; Dugoff L; Craigo SD; Timor-Tritsch IE; Carr SR; Wolfe HM; Tripp T; Bianchi DW; D'Alton ME; Obstet Gynecol; 2007 Sep; 110(3):651-7. PubMed ID: 17766613 [TBL] [Abstract][Full Text] [Related]
19. Dehydrosteroid measurements in maternal urine or serum for the prenatal diagnosis of Smith-Lemli-Opitz syndrome (SLOS). Shackleton CH; Marcos J; Palomaki GE; Craig WY; Kelley RI; Kratz LE; Haddow JE Am J Med Genet A; 2007 Sep; 143A(18):2129-36. PubMed ID: 17702049 [TBL] [Abstract][Full Text] [Related]
20. [Serum screening of fetal chromosome abnormality during second pregnancy trimester: results of 26,803 pregnant women in Jiangsu Province]. Hu YL; Zhonghua Yi Xue Za Zhi; 2007 Sep; 87(35):2476-80. PubMed ID: 18067809 [TBL] [Abstract][Full Text] [Related] [Next] [New Search]